These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 1930486

  • 1. [Early detection of cisplatin-induced ototoxicity using evoked otoacoustic emissions].
    Plinkert PK, Kröber S.
    Laryngorhinootologie; 1991 Sep; 70(9):457-62. PubMed ID: 1930486
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P, Apostolopoulos N, Segas J, Tsakanikos M, Adamopoulos G.
    Int J Pediatr Otorhinolaryngol; 2001 May 31; 59(1):47-57. PubMed ID: 11376818
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of treatment with vincristine on transient evoked and distortion product otoacoustic emissions.
    Riga M, Psarommatis I, Korres S, Lyra Ch, Papadeas E, Varvutsi M, Ferekidis E, Apostolopoulos N.
    Int J Pediatr Otorhinolaryngol; 2006 Jun 31; 70(6):1003-8. PubMed ID: 16359737
    [Abstract] [Full Text] [Related]

  • 9. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S.
    Laryngorhinootologie; 1996 Dec 31; 75(12):709-18. PubMed ID: 9081275
    [Abstract] [Full Text] [Related]

  • 10. Distortion-product otoacoustic emission: early detection in deferoxamine induced ototoxicity.
    Delehaye E, Capobianco S, Bertetto IB, Meloni F.
    Auris Nasus Larynx; 2008 Jun 31; 35(2):198-202. PubMed ID: 17869044
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity.
    Hotz MA, Harris FP, Probst R.
    Laryngoscope; 1994 Sep 31; 104(9):1130-4. PubMed ID: 8072361
    [Abstract] [Full Text] [Related]

  • 15. Otoacoustic emissions and effects of contralateral white noise stimulation on transient evoked otoacoustic emissions in diabetic children.
    Ugur AK, Kemaloglu YK, Ugur MB, Gunduz B, Saridogan C, Yesilkaya E, Bideci A, Cinaz P, Goksu N.
    Int J Pediatr Otorhinolaryngol; 2009 Apr 31; 73(4):555-9. PubMed ID: 19150138
    [Abstract] [Full Text] [Related]

  • 16. Otoacoustic emissions--an approach for monitoring aminoglycoside induced ototoxicity in children.
    Stavroulaki P, Apostolopoulos N, Dinopoulou D, Vossinakis I, Tsakanikos M, Douniadakis D.
    Int J Pediatr Otorhinolaryngol; 1999 Nov 05; 50(3):177-84. PubMed ID: 10595663
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Transient-evoked otoacoustic emissions in children after cisplatin chemotherapy.
    Allen GC, Tiu C, Koike K, Ritchey AK, Kurs-Lasky M, Wax MK.
    Otolaryngol Head Neck Surg; 1998 May 05; 118(5):584-8. PubMed ID: 9591854
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.